Compounds > moxifloxacin
Page last updated: 2024-09-04

moxifloxacin and cefoxitin

moxifloxacin has been researched along with cefoxitin in 15 studies

Compound Research Comparison

Studies
(moxifloxacin)		Trials
(moxifloxacin)		Recent Studies (post-2010)
(moxifloxacin)		Studies
(cefoxitin)		Trials
(cefoxitin)		Recent Studies (post-2010) (cefoxitin)
3,1575521,6902,131362328

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (6.67)18.2507
2000's8 (53.33)29.6817
2010's4 (26.67)24.3611
2020's2 (13.33)2.80

Authors

AuthorsStudies
Choi, TY; Pai, H; Seo, MR1
Finegold, SM; Golan, Y; Goldstein, EJ; Gorbach, SL; Harrell, LJ; Hecht, DW; Jacobus, NV; Jenkins, SG; McDermott, LA; Pierson, C; Rihs, J; Ruthazer, R; Snydman, DR; Venezia, R; Yu, V1
Bryk, A; Kanervo-Nordström, A; Könönen, E; Niemi, P1
Calvet, L; Devine, R; Dubreuil, L; Jean-Pierre, H; Jumas-Bilak, E; Marchandin, H; Mercier, G; Morio, F1
Lombardo, F; Obach, RS; Waters, NJ1
Betriu, C; Culebras, E; Gómez, M; López, F; Picazo, JJ; Rodríguez-Avial, I1
Jacobus, NV; McDermott, LA; Snydman, DR1
Chong, Y; Jeong, SH; Kim, MS; Lee, K; Lee, Y; Park, Y; Yong, D1
Hamprecht, A; Higgins, PG; Schneiders, T; Seifert, H1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Edlund, C; Nord, CE; Sabouri, S1
Claeys, G; Delmée, M; Glupczynski, Y; Gordts, B; Ieven, M; Lauwers, S; Melin, P; Piérard, D; Reynders, M; Struelens, M; Vandoorslaer, K; Verhaegen, J; Verschraegen, I; Wybo, I1
Lu, J; Pang, Y; Song, Y; Zhang, Z1
Li, J; Li, N; Liu, B; Lü, X; Wang, H; Zhang, Y1
Arslan, N; Esen, N; Özkarataş, MH; Özkütük, AA1

Reviews

1 review(s) available for moxifloxacin and cefoxitin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

14 other study(ies) available for moxifloxacin and cefoxitin

ArticleYear
Association of QnrB determinants and production of extended-spectrum beta-lactamases or plasmid-mediated AmpC beta-lactamases in clinical isolates of Klebsiella pneumoniae.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:1

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Quinolones

2007
National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:5

    Topics: Anti-Bacterial Agents; Bacteroides; Bacteroides fragilis; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Time Factors; United States

2007
Antimicrobial susceptibilities of Peptostreptococcus anaerobius and the newly described Peptostreptococcus stomatis isolated from various human sources.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6

    Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteremia; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Peptostreptococcus; Species Specificity

2007
Antimicrobial susceptibilities and clinical sources of Dialister species.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:12

    Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Species Specificity; Veillonellaceae

2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Resistance trends of the Bacteroides fragilis group over a 10-year period, 1997 to 2006, in Madrid, Spain.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:7

    Topics: Anti-Bacterial Agents; Bacteroides; Bacteroides fragilis; Bacteroides Infections; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Spain; Species Specificity; Time Factors

2008
In vitro activities of doripenem, a new broad-spectrum carbapenem, against recently collected clinical anaerobic isolates, with emphasis on the Bacteroides fragilis group.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:12

    Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Carbapenems; Doripenem; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests

2008
Antimicrobial susceptibility patterns for recent clinical isolates of anaerobic bacteria in South Korea.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:9

    Topics: Anti-Infective Agents; Aza Compounds; Bacteria, Anaerobic; Bacteroides fragilis; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Positive Cocci; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Republic of Korea

2010
In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; Carbapenems; Drug Resistance, Bacterial; Fatal Outcome; Humans; Male; Middle Aged; Molecular Sequence Data; Mutation, Missense; Reverse Transcriptase Polymerase Chain Reaction

2010
Comparative in vitro activity of BAY 12-8039 and five other antimicrobial agents against anaerobic bacteria.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1998, Volume: 17, Issue:3

    Topics: Anti-Infective Agents; Aza Compounds; Bacteria, Anaerobic; Cefoxitin; Cephamycins; Clindamycin; Fluoroquinolones; Imipenem; Metronidazole; Moxifloxacin; Ofloxacin; Quinolines; Quinolones; Thienamycins

1998
Third Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria.
    The Journal of antimicrobial chemotherapy, 2007, Volume: 59, Issue:1

    Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Aza Compounds; Bacteria, Anaerobic; beta-Lactamases; Cefoxitin; Fluoroquinolones; Microbial Sensitivity Tests; Moxifloxacin; Penicillins; Quinolines

2007
In vitro activity between linezolid and other antimicrobial agents against Mycobacterium abscessus complex.
    Diagnostic microbiology and infectious disease, 2018, Volume: 90, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; DNA-Directed RNA Polymerases; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; Humans; Linezolid; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Tigecycline

2018
Antibiotic susceptibility and biofilm-forming ability of Veillonella strains.
    Anaerobe, 2022, Volume: 78

    Topics: Ampicillin; Anti-Bacterial Agents; Biofilms; Cefoxitin; Clindamycin; Humans; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Piperacillin; Tazobactam; Tetracyclines; Vancomycin; Veillonella

2022
[Evaluation of Antimicrobial Susceptibilities of Rapidly Growing Mycobacteria].
    Mikrobiyoloji bulteni, 2023, Volume: 57, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Ciprofloxacin; Clarithromycin; Doxycycline; Humans; Imipenem; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Tobramycin

2023